Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Upcoming Webinar on Tuesday, June 29 - FDA Center for Tobacco Products: Inaugural Year and Looking Forward

SILVER SPRING, Md., June 25 /PRNewswire-USNewswire/ -- How can death and disease associated with tobacco use be reduced? What is the Food and Drug Administration (FDA) doing to prevent our children from becoming the next generation of Americans to die prematurely from tobacco use?

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

Learn more when FDA's Center for Tobacco Products hosts a 30-minute webinar on its inaugural year and its plans for the future. An opportunity to ask questions will follow the presentation.

When: Tuesday, June 29, 2010, at 11 a.m. Eastern Time

Where: To join the webinar, see the instructions at http://www.fda.gov/AboutFDA/Basics/ucm216530.htm. Webinar materials will also be made available here.

Host: FDA's Center for Tobacco Products phone: 1-877-287-1373 e-mail: AskCTP@fda.hhs.gov

Featured speaker: Lawrence R. Deyton, M.S.P.H., M.D., director, FDA's Center for Tobacco Products.

Background: On June 22, 2009, President Obama signed the historic Family Smoking Prevention and Tobacco Control Act. This legislation gave FDA authority to regulate tobacco products, with a special emphasis on preventing their use by children and youth and reducing the impact of tobacco on public health. The act authorizes FDA to set tobacco product standards, require product listing and registration, revise health warning labels, create manufacturing standards, and review products intended to modify the risk of tobacco use.

Note: On June 30, 2010, FDA's Center for Tobacco Products will be holding a separate Web-based public meeting on issues related to the development of a plan to enforce restrictions on the promotion and advertising of cigarettes to youth. For more information, see http://www.fda.gov/TobaccoProducts/NewsEvents/ucm215780.htm.

This webinar is the fifth in a series of monthly online sessions hosted by different FDA centers and offices. The series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.

Find out more about FDA's role in tobacco product regulation at http://www.fda.gov/TobaccoProducts/NewsEvents/ucm216493.htm and http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm183919.htm

Sign up for e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9

View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (http://www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

Media Contact: Jason Brodsky at 301-796-8234; jason.brodsky@fda.hhs.gov

Photo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO
PRN Photo Desk, photodesk@prnewswire.com
http://photos.prnewswire.com/prnh/20090824/FDALOGO

U.S. Food and Drug Administration

CONTACT: Jason Brodsky of the FDA, +1-301-796-8234;
jason.brodsky@fda.hhs.gov

Web Site: http://www.fda.gov/

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.